Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical Outcome

NCT00167024CI-TRIAL-00000225unknownClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

Primary: to investigate the effects of DNA repair gene polymorphisms on prostate cancer susceptibility, pathological grade, disease stage and clinical outcome Secondary: to understand the association between DNA repair gene polymorphism and prostate cancer and provided important information for screening, prevention and treatment of prostate cancer

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Prostate Cancer	Malignant Prostate Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: Male
Minimum age: 0 Years

Show eligibility criteria text

Inclusion Criteria:

* prostate cancer approved by pathology

Exclusion Criteria:

* combined with other malignancy
* accepting blood transfusion within 6 months

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Mar 1, 2005
Primary completion: —
Completion: —
First posted: Sep 14, 2005
Last update posted: Nov 28, 2005
Enrollment: 100
Lead sponsor: National Taiwan University Hospital OTHER
Keywords: prostate cancer, DNA repair gene, genetic polymorphism

Data updated 22 days agoSource updated Nov 28, 2005source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
Taiwan	1	1

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.